Skip to content

The Prevalence of Lower Urinary Tract Symptoms (LUTS) in Poland

The Prevalence of Lower Urinary Tract Symptoms (LUTS) in Poland: Epidemiology of LUTS (Poland LUTS) Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04121936
Enrollment
6000
Registered
2019-10-10
Start date
2019-11-11
Completion date
2021-06-01
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Evaluate Lower Urinary Tract Symptoms (LUTS) in Poland

Brief summary

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland.

Detailed description

The first large population-based study to evaluate lower urinary tract symptoms (LUTS) in Poland. The study objective is to assess the prevalence and bother of LUTS in the population aged ≥40 years in Poland. This study will be conducted as a telephone survey with assessment of LUTS using a standardized protocol, which included the International Prostate Symptom Score (IPSS) and, for overactive bladder (OAB), the OAB-V8 questionnaire. Participants will be asked to rate how often they experienced individual LUTS and the degree of associated bother. The study will be performed in a representative group of Polish population (n = 6,000) covering all geographic regions of Poland (defined by the Central Statistical Office of Poland).

Interventions

There will be no intervention

Sponsors

Piotr Chlosta
CollaboratorUNKNOWN
Jagiellonian University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

Age \>40

Exclusion criteria

Age \<40 Pregnancy Urinary tract infection in the past 4 weeks

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of LUTSThrough study completion, an average of 3 monthsThe prevalence of LUTS will be assessed using definitions of the International Continence Society (descriptive statistics).
Symptom bother of LUTSThrough study completion, an average of 3 monthsThe degree of associated bother will be assessed using Likert scale (Likert scale: not at all \[score 0\], a little bit \[score 1\], somewhat \[score 2\], quite a bit \[score 3\], a great deal \[score 4\], or a very great deal \[score 5\]).

Secondary

MeasureTime frameDescription
Prevalence of specific symptomsThrough study completion, an average of 3 monthsThe prevalence of specific symptoms will be assessed using a standardised protocol based on the definitions provided by the International Continence Society (i.e. storage symptoms, voiding symptoms and post-micturition symptoms) \[Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167-178\]. Participants will be asked to rate how often they experienced individual LUTS during the past month. A Likert scale will be used with the following options: none (score 0), \<1 in 5 times (score 1), \<half the time (score 2), about half the time (score 3), \>half the time (score 4), or almost always (score 5).
Symptom bother of specific symptomsThrough study completion, an average of 3 monthsThe degree of associated bother of specific symptoms will be assessed using Likert scale (Likert scale: not at all \[score 0\], a little bit \[score 1\], somewhat \[score 2\], quite a bit \[score 3\], a great deal \[score 4\], or a very great deal \[score 5\]).
Prevalence of OABThrough study completion, an average of 3 monthsThe prevalence of OAB will be assessed with the Overactive Bladder-Validated 8-question Screener (OAB-V8)questionnaire.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026